Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

This journal offers Accelerated Publication.

Articles:

Latest articles:

- 5 records -

Original Research

Alcohol Cues Elicit Differences in Brain Activation Patterns of Abstinent Men and Women with Alcohol Use Disorders

Sawyer KS, Oscar-Berman M, Ruiz SM, Marinkovic K, Valmas MM, Harris GJ

Neuropsychiatric Disease and Treatment 2026, 22:551536

Published Date: 8 June 2026

Original Research

Echinocystic Acid Antagonizes Post-Stroke Depression in Mice by Suppressing the JNK/NF-κB Signaling Pathway

Wang D, Li W, Zhang X, Zhu K, Wang Y, Cai Y, Chen H, Cai X, Sun J

Neuropsychiatric Disease and Treatment 2026, 22:596008

Published Date: 5 June 2026

Original Research

Peripheral Nerve Conduction in Alzheimer’s vs. Late-Life Depression: A Comparative Study

Li X, Zhao X, Huang Y, Tang J

Neuropsychiatric Disease and Treatment 2026, 22:611214

Published Date: 4 June 2026

Review

Integration of Traditional Chinese Medicine and Psychotherapy in Mental Health: A Narrative Review of Mechanisms, Clinical Evidence, and Future Directions

Du J, Tan Y

Neuropsychiatric Disease and Treatment 2026, 22:607443

Published Date: 3 June 2026

Review

Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis

Kumar R, Hashempour Z, Shahriarirad S, Shahriarirad R, Hassett LC, Singh B, Croarkin PE, Veldic M, Frye MA, Pagali SR

Neuropsychiatric Disease and Treatment 2026, 22:586506

Published Date: 3 June 2026